Veröffentlichungen | MDC Berlin

19 Ergebnisse:

Active Filter:

01. Mai 2010 in Nat Med

Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma

B. Lamprecht
K. Walter
S. Kreher
R. Kumar
M. Hummel
D. Lenze
K. Koechert
M.A. Bouhlel
J. Richter
E. Soler
R. Stadhouders
K. Joehrens
K.D. Wurster
D.F. Callen
M.F. Harte
M. Giefing
R. Barlow
H. Stein
I. Anagnostopoulos
M. Janz
P.N. Cockerill
R. Siebert
B. Doerken
C. Bonifer
S. Mathas

15. April 2010 in Clin Cancer Res

T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy

M. Leisegang
A. Turqueti-Neves
B. Engels
T. Blankenstein
D.J. Schendel
W. Uckert
E. Noessner

15. Oktober 2007 in J Immunol

Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity

M. Weinhold
D. Sommermeyer
W. Uckert
T. Blankenstein

01. Mai 2007 in Br J Haematol

Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis

A. Lietz
M. Janz
M. Sigvardsson
F. Jundt
B. Doerken
S. Mathas

01. April 2007 in Leukemia

Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells

M. Janz
T. Stuehmer
L.T. Vassilev
R.C. Bargou

01. November 2006 in Eur J Immunol

Designer T cells by T cell receptor replacement

D. Sommermeyer
J. Neudorfer
M. Weinhold
M. Leisegang
B. Engels
E. Noessner
M.H. Heemskerk
J. Charo
D.J. Schendel
T. Blankenstein
H. Bernhard
W. Uckert

15. Mai 2006 in Cell Cycle

Reprogramming of B lymphoid cells in human lymphoma pathogenesis

M. Janz
B. Doerken
S. Mathas

01. April 2006 in Cell Death Differ

Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma

I. Sturm
C. Stephan
B. Gillissen
R. Siebert
M. Janz
S. Radetzki
K. Jung
S. Loening
B. Doerken
P.T. Daniel

15. März 2006 in Blood

Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells

M. Janz
M. Hummel
M. Truss
B. Wollert-Wulf
S. Mathas
K. Joehrens
C. Hagemeier
K. Bommert
H. Stein
B. Doerken
R.C. Bargou

01. Februar 2006 in Nat Immunol

Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma

S. Mathas
M. Janz
F. Hummel
M. Hummel
B. Wollert-Wulf
S. Lusatis
I. Anagnostopoulos
A. Lietz
M. Sigvardsson
F. Jundt
K. Joehrens
K. Bommert
H. Stein
B. Doerken